Pharma

A close that survives diligence.

The jump to a public company standard close usually comes before the finance function is built for it. Accruals and workpapers have to hold up when a diligence team or an auditor starts pulling threads. We have lived this firsthand.

The pattern that is yours

What we see most in this world

A small company carrying a clinical trial close

Surviving a clinical trial grade close cadence, with FDA study accruals, without the team a large sponsor has.

Accruals and workpapers that will not hold up

Manual, undocumented processes that a diligence team or auditor can unravel.

Financials not ready for scrutiny

Reporting that is not ready for the level of review a raise, a partnership, or a listing brings.

Milestone and program spend is unclear

Limited visibility into spend by program against the next financing.

How we help

From murky to buttoned up

We bring clinical trial grade rigor to the close, build FDA study accruals and workpapers that survive diligence, and give you clean, defensible financials for a partnership, a financing, or a listing.

The numbers that matter here

  • Close quality and timeliness
  • Accrual accuracy
  • Program level spend
  • Cash to next financing

Where this usually lands

A drug developer preparing for diligence or a transaction often fits Exit. A company that needs a diligence resilient close and reporting fits Scale.

Signals you are ready

Trigger events

  • Preparing for diligence, a partnership, or a transaction
  • Running human or animal clinical trials with complex accruals
  • A board or audit committee raising the bar on the close
  • A milestone payment or financing event

Why Shawn

As an outside contractor on the accounting team, Shawn provided pharmaceutical clinical trial accounting for a client, learning the rigor of FDA clinical trial accrual methodologies for both human and animal clinical trials. He was part of the team, not the CFO.

Read Shawn's track record

Questions founders ask

Quick answers

What does a public company standard close require?
A fast, documented, accrual based close, with accruals and workpapers that hold up to audit and diligence even at a small company size. It is as much about discipline and documentation as it is about the numbers.
How do you build accruals and workpapers that survive diligence?
By replacing manual, undocumented steps with a documented, repeatable process where every accrual is supported and traceable. A diligence team or an auditor will pull threads, and undocumented judgment is where things unravel.
Do you have pharmaceutical clinical trial accounting experience?
Yes. Working with a pharmaceutical client, Shawn learned the rigor of FDA clinical trial accrual methodologies for both human and animal clinical trials, and supported the accrual accounting and monthly close for that work. That clinical trial grade discipline carries weight because it is lived, not theory.
Can you support a transaction or partnership?
Yes. At the Exit tier we bring in room presence and transaction support alongside your counsel, while staying clear of legal advice. We handle the financial side while your attorney handles theirs.

The first step

See where you fit.

A short conversation about where you are and what you need. If we are a fit, we will tell you how we would help.

See If We Are a Fit (15 minutes)